Glow Recipe Watermelon Glow PHA +BHA Pore-Tight Toner by Glow Recipe
Glow Recipe

Glow Recipe Watermelon Glow PHA +BHA Pore-Tight Toner

Toners

Safety score

Pregnancy-focused assessment

Low Risk71/100
Higher concernLower concern

One or more ingredients have a low-risk flag in MamaSkin's current assessment. Review the notes and your own circumstances.

Formula and assessment check

Ingredient safety review updated 22 January 2026. Product formulas can change, so compare the ingredients shown here with the packaging you have.

Report a formula mismatch

Ingredient breakdown

See how the listed formula falls across MamaSkin's pregnancy-focused risk bands.

17

No known risks

5

Low risk

0

Medium risk

0

High risk

Ingredients

Ingredients with a higher risk flag appear first, followed by the rest of the formula.

Parfum

Low Risk

Umbrella term for an undisclosed fragrance blend. It’s not usually a pregnancy-specific concern at normal cosmetic use levels, but the exact components and concentrations aren’t fully disclosed on the label, so we score it more conservatively. If you prefer maximum transparency (or you’re sensitive to fragrance compounds), choose fragrance-free/unscented products.

Sources: SCCS: Fragrance allergens in cosmetic products https://health.ec.europa.eu/latest-updates/sccs-new-opinion-fragrance-allergens-cosmetic-products-2012-07-31_en

Gluconolactone

Low Risk

Polyhydroxy acid (PHA) used as a gentle exfoliant/humectant; generally less irritating than AHAs due to lower penetration. Considered safe as used in cosmetics, with no pregnancy-specific contraindications identified at topical cosmetic concentrations.

Sources: MotherToBaby: Topical acne treatments in pregnancy and breastfeeding https://www.ncbi.nlm.nih.gov/books/NBK582985/

Betaine Salicylate

Low Risk

Ester form of salicylic acid; hydrolyses to SA, low-strength topical use shows negligible systemic absorption - chemical peels ≥30 % should be avoided.

Sources: MotherToBaby: Topical acne treatments including salicylic acid https://www.ncbi.nlm.nih.gov/books/NBK582985/

Show all (22)

Salix Alba Bark Extract

Low Risk

Willow bark is a salicin-containing botanical material. Its composition and delivered salicylate exposure vary by species, plant part, extraction method and concentration, so a cosmetic extract should not be treated as dose-equivalent to a stated concentration of salicylic acid. MamaSkin retains Low Risk as a conservative family policy for ordinary topical cosmetic use; this does not cover oral willow-bark medicines, concentrated preparations, large-area use or salicylate allergy.

Sources: EMA/HMPC: Salicis cortex assessment and monograph materials https://www.ema.europa.eu/en/medicines/herbal/salicis-cortex; CIR 2026 review materials for Salix alba-derived cosmetic ingredients https://www.cir-safety.org/panelbook/safety-assessment-salix-alba-willow-derived-ingredients-used-cosmetics

Glycyrrhiza Glabra Root Extract

Low Risk

Pregnancy concerns around licorice are based mainly on high oral glycyrrhizin intake, which has been linked to shorter gestation and cortisol-related effects in offspring; by contrast, licorice root extracts have been assessed as safe as used in cosmetics, so routine topical skincare exposure fits a cautious low-risk classification.

Sources: CIR: Cosmetic safety assessment covering Glycyrrhiza glabra-derived ingredients https://cir-reports.cir-safety.org/view-attachment/?id=49a63435-8e74-ec11-8943-0022482f06a6

Opuntia Ficus-Indica Extract

No Known Risks

opuntia ficus-indica extract is a botanical-derived cosmetic conditioning ingredient. The reviewed identity is not a concentrated essential oil or an oral herbal preparation. Available cosmetic evidence and expected topical exposure did not identify a pregnancy-specific contraindication, although botanical irritation or allergy remains possible.

Sources: CIR ingredient-specific and botanical-family safety assessments; CIR Quick Reference Table https://www.cir-safety.org/supplementaldoc/quick-reference-table-december-2025; European Commission CosIng

Citrullus Lanatus Fruit Extract

No Known Risks

A fruit, seed or food-plant extract used for skin conditioning and antioxidant support. No pregnancy-specific signal was identified for the low topical exposure expected from a finished cosmetic. Direct pregnancy studies are generally unavailable, and botanical allergy remains possible.

Sources: European Commission CosIng ingredient inventory; CIR botanical safety framework and relevant fruit-derived ingredient assessments; peer-reviewed cosmetic and phytochemical literature for the named plants.

Glycerin

No Known Risks

Glycerin is a widely used humectant that supports hydration and the skin barrier, with a long safety record and no known pregnancy or breastfeeding concerns in topical cosmetic use.

Sources: CIR; EU/UK Cosmetics Regulation

Hyaluronic Acid

No Known Risks

High-water-binding humectant used to support hydration at the skin surface. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified in the material reviewed.

Sources: CIR: Safety Assessment of Hyaluronates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory

Sodium Polyglutamate

No Known Risks

A high-molecular-weight glutamic-acid polymer salt used as a humectant and skin conditioner. Its molecular size limits meaningful skin penetration. No reproductive or developmental concern was identified for normal topical cosmetic exposure.

Sources: European Commission CosIng ingredient inventory; peer-reviewed cosmetic literature on polyglutamic acid and sodium polyglutamate.

Melaleuca Alternifolia Leaf Extract

No Known Risks

A tea-tree leaf extract used for skin conditioning and antimicrobial support. Cosmetic safety reviewers concluded that the assessed Melaleuca alternifolia-derived ingredients are safe in current practices when formulated to be non-sensitising. This leaf extract is distinct from concentrated tea-tree essential oil, although botanical allergy remains possible.

Sources: CIR: Safety Assessment of Melaleuca alternifolia-Derived Ingredients as Used in Cosmetics https://cir-reports.cir-safety.org/view-attachment/?id=e1f5b6e9-8c74-ec11-8943-0022482f06a6

Hibiscus Sabdariffa Flower Extract

No Known Risks

A plant-part extract used for skin conditioning, soothing, fragrance or antioxidant support. No pregnancy-specific systemic signal was identified for normal topical cosmetic exposure. This assessment does not extend to essential oils, oral herbal products or medicinal doses, and botanical sensitivity remains possible.

Sources: European Commission CosIng ingredient inventory; CIR botanical safety framework and relevant plant-derived ingredient assessments; peer-reviewed cosmetic-use literature.

Lactobacillus/Watermelon Fruit Ferment Extract

No Known Risks

Cucumis Sativus Fruit Extract

No Known Risks

A cucumber fruit extract used for skin conditioning. Cosmetic safety reviewers concluded that Cucumis sativus-derived ingredients are safe in current cosmetic practices of use and concentration when formulated to avoid sensitisation. No pregnancy-specific concern was identified for normal topical cosmetic exposure, although irritation or allergy to a botanical-containing formula remains possible.

Sources: CIR: Final Safety Assessment of Cucumis sativus (Cucumber)-Derived Ingredients https://cir-safety.org/supplementaldoc/final-safety-assessment-cucumis-sativus-cucumber-derived-ingredients

Saccharum Officinarum Extract

No Known Risks

A sugarcane extract used for skin conditioning and moisturising. Cosmetic safety reviewers concluded that Saccharum officinarum extract is safe in current cosmetic practices of use and concentration. It is not the same as a formulated high-strength alpha-hydroxy-acid peel, and no pregnancy-specific concern was identified for normal topical cosmetic exposure.

Sources: CIR: Safety Assessment of Saccharum officinarum (Sugarcane)-Derived Ingredients as Used in Cosmetics https://www.cir-safety.org/supplementaldoc/safety-assessment-saccharum-officinarum-sugarcane-derived-ingredients-used-cosmetics

Scutellaria Baicalensis Root Extract

No Known Risks

A Chinese skullcap root extract used for skin conditioning and antioxidant effects. Cosmetic safety reviewers concluded that the root extract is safe in current practices of use and concentration; this conclusion does not extend to the generic whole-plant or sprout extracts, for which evidence was insufficient. No pregnancy-specific concern was identified for normal topical cosmetic exposure.

Sources: CIR: Safety Assessment of Scutellaria baicalensis-Derived Ingredients as Used in Cosmetics https://cir-reports.cir-safety.org/view-attachment/?id=12155820-bce2-80f8-bd06-353ba20e5877

Paeonia Suffruticosa Root Extract

No Known Risks

A tree-peony root extract used for skin conditioning and antioxidant support. No pregnancy- or breastfeeding-specific hazard was identified for normal topical cosmetic exposure. Direct ingredient-specific pregnancy studies were not identified, so this assessment does not extend to oral supplements or medicinal use.

Sources: European Commission CosIng ingredient inventory; Cosmetic Ingredient Review botanical safety-assessment framework and relevant ingredient-family assessments. No ingredient-specific human pregnancy study of normal topical cosmetic use was identified.

Brassica Oleracea Capitata Leaf Extract

No Known Risks

A botanical extract, plant water or plant juice used for conditioning, soothing or antioxidant support. Direct pregnancy studies of this exact cosmetic material were not identified, but no reproductive or developmental hazard was identified for normal topical exposure. Oral herbal or medicinal use is outside this classification.

Sources: European Commission CosIng ingredient inventory; CIR botanical safety framework and relevant plant-derived ingredient assessments; no ingredient-specific human pregnancy study of normal topical cosmetic use was identified.

Ipomoea Batatas Root Extract

No Known Risks

ipomoea batatas root extract is a defined, non-essential-oil botanical cosmetic ingredient. The reviewed identity and expected topical exposure did not identify a pregnancy-specific contraindication. Cosmetic-grade purity remains important, and botanical irritation or allergy is still possible.

Sources: CIR ingredient-specific and botanical-family assessments; CIR Quick Reference Table https://www.cir-safety.org/supplementaldoc/quick-reference-table-december-2025; European Commission CosIng ingredient inventory.

Sorbitan Oleate

No Known Risks

This sorbitan fatty-acid ester is an emulsifier that helps oil and water phases remain mixed. The Cosmetic Ingredient Review concluded that sorbitan esters are safe in current cosmetic use; occasional contact reactions remain possible in sensitive users.

Sources: CIR: Safety Assessment of Sorbitan Esters as Used in Cosmetics https://www.cir-safety.org/supplementaldoc/safety-assessment-sorbitan-esters-used-cosmetics

Levulinic Acid

No Known Risks

An organic acid used for pH adjustment, fragrance or preservative support. Cosmetic safety reviewers concluded that levulinic acid and its salts are safe in current cosmetic practices.

Sources: CIR: Levulinic Acid and salts conclusion, IJT 44(Suppl. 3), 2025; December 2025 Quick Reference Table https://cir-safety.org/sites/default/files/QRT-Update-Dec2025.pdf

Sodium Levulinate

No Known Risks

The sodium salt of levulinic acid, used for skin conditioning and formulation support and often as part of a preservation system. Cosmetic safety reviewers concluded that sodium levulinate is safe in current cosmetic use when formulated to be non-irritating. Cosmetic exposure is low compared with established food-related exposure, and no pregnancy-specific concern is identified for normal topical use.

Sources: CIR: September 2021 Final Report announcement for Levulinic Acid and Sodium Levulinate https://cir-safety.org/sites/default/files/PMA_Sep2021_final.pdf

Formulations can change without notice. For the most accurate result, compare this list with your packaging and scan the exact ingredient label in MamaSkin when you repurchase.

How to use this assessment

The risk band is the primary conclusion. The score adds detail within that band and should not be used to compare products as if a one-point difference were clinically meaningful.

MamaSkin provides pregnancy-focused information, not medical advice. Your midwife, GP, pharmacist or dermatologist should take priority when your circumstances differ from typical cosmetic use.

Read the full methodology